S&P 500 · settore · 60 aziende
Le azioni del settore Sanità nell'S&P 500
Nei più recenti esercizi le aziende del settore hanno avuto ricavi complessivi di $3,66 trn e un utile netto di $196 mld (5,4% dei ricavi). La più grande per ricavi è UnitedHealth Group.
Ricavi complessivi nell'ultimo esercizio, 60 aziende
$3,66 trn+9,1% l'anno
crescita mediana dei ricavi su 10 anni (53 aziende)
Aziende
60
sotto-industrie: 10
Utile netto complessivo
$196 mld
5,4% di ricavi
Margine netto mediano
13,0%
ultimo esercizio
Pagano un dividendo
37 su 60
lo hanno aumentato ogni anno nei dati: 7 aziende
Meno azioni di 10 anni fa
31 su 57
variazione mediana −5,8%
Ricavi e utile netto complessivi dal 2010
I ricavi delle aziende con dati per ogni anno (48) sono passati da $980 mld nel 2010 a $3,33 trn nel 2025, 8,5% l'anno.
RicaviUtile netto
Non è stato possibile caricare i dati del grafico. La tabella qui sotto riporta gli stessi valori.
Aziende
| UnitedHealth Group | UNH | Managed Health Care | 2025 | $448 mld | $12,1 mld | 2,7% | 11,7% | 11,0% | 8,2% | $8,73 | 16 | −5,8% |
| McKesson | MCK | Health Care Distributors | 2026 | $403 mld | $4,76 mld | 1,2% | 11,1% | 7,8% | 14,7% | $3,17 | 13 | −46,7% |
| CVS Health | CVS | Health Care Services | 2025 | $402 mld | $1,77 mld | 0,4% | 8,4% | 10,1% | −11,3% | $2,66 | 0 | +12,9% |
 Cencora | COR | Health Care Distributors | 2025 | $321 mld | $1,55 mld | 0,5% | 11,1% | 9,0% | — | $2,20 | 17+ | −10,4% |
| Cigna | CI | Health Care Services | 2025 | $275 mld | $5,96 mld | 2,2% | 11,4% | 21,9% | 10,7% | $6,04 | 5 | +3,1% |
 Cardinal Health | CAH | Health Care Distributors | 2026 | $254 mld | $1,71 mld | 0,7% | 9,4% | 7,7% | 5,3% | $2,04 | 18+ | −28,2% |
 Elevance Health | ELV | Managed Health Care | 2025 | $199 mld | $5,66 mld | 2,8% | 10,3% | 9,7% | 10,4% | $6,84 | 14 | −17,7% |
 Centene Corporation | CNC | Managed Health Care | 2025 | $195 mld | −$6,67 mld | −3,4% | 11,9% | 23,9% | — | — | — | +100,3% |
 Humana | HUM | Managed Health Care | 2025 | $130 mld | $1,19 mld | 0,9% | 10,9% | 9,1% | 1,5% | $3,54 | 0 | −20,1% |
| Johnson & Johnson | JNJ | Pharmaceuticals | 2025 | $94,2 mld | $26,8 mld | 28,5% | 2,7% | 3,0% | 7,2% | $5,14 | 18+ | −13,6% |
 HCA Healthcare | HCA | Health Care Facilities | 2025 | $75,6 mld | $6,78 mld | 9,0% | 8,0% | — | 19,0% | $2,88 | 5 | −43,9% |
 Lilly (Eli) | LLY | Pharmaceuticals | 2025 | $65,2 mld | $20,6 mld | 31,7% | 21,6% | 12,6% | 26,1% | $6,23 | 9 | −15,6% |
 Merck & Co. | MRK | Pharmaceuticals | 2025 | $65 mld | $18,3 mld | 28,1% | 9,4% | 5,1% | 16,7% | $3,28 | 15 | −11,8% |
 Pfizer | PFE | Pharmaceuticals | 2025 | $62,6 mld | $7,77 mld | 12,4% | 8,5% | 2,5% | 2,1% | $1,72 | 15 | −8,7% |
 AbbVie | ABBV | Biotechnology | 2025 | $61,2 mld | $4,23 mld | 6,9% | 6,0% | 10,3% | −2,8% | $6,65 | 11 | +8,3% |
 Bristol Myers Squibb | BMY | Pharmaceuticals | 2025 | $48,2 mld | $7,05 mld | 14,6% | 2,5% | 11,3% | 14,0% | $2,49 | 18+ | +21,4% |
 Thermo Fisher Scientific | TMO | Life Sciences Tools & Services | 2025 | $44,6 mld | $6,7 mld | 15,0% | 6,7% | 10,1% | 13,7% | $1,72 | 8 | −6,0% |
 Abbott Laboratories | ABT | Health Care Equipment | 2025 | $44,3 mld | $6,52 mld | 14,7% | 5,1% | 8,1% | 2,5% | $2,40 | 3 | +16,1% |
 Amgen | AMGN | Biotechnology | 2025 | $36,8 mld | $7,71 mld | 21,0% | 7,6% | 5,4% | 4,6% | $9,66 | 12 | −29,2% |
 Medtronic | MDT | Health Care Equipment | 2026 | $36,4 mld | $4,8 mld | 13,2% | 3,8% | 2,3% | 4,2% | $2,84 | 18+ | −9,7% |
| Gilead Sciences | GILD | Biotechnology | 2025 | $29,4 mld | $8,51 mld | 28,9% | 3,6% | −1,0% | −5,5% | $3,16 | 10 | −17,5% |
 Stryker Corporation | SYK | Health Care Equipment | 2025 | $25,1 mld | $3,25 mld | 12,9% | 11,8% | 9,7% | 8,3% | $3,40 | 16 | +1,5% |
 Danaher Corporation | DHR | Life Sciences Tools & Services | 2025 | $24,6 mld | $3,61 mld | 14,7% | 2,0% | — | 0,6% | — | — | +1,1% |
 Becton Dickinson | BDX | Health Care Equipment | 2025 | $21,8 mld | $1,68 mld | 7,7% | 6,3% | 7,8% | 5,7% | $4,16 | 12 | +39,0% |
| GE HealthCare | GEHC | Health Care Equipment | 2025 | $20,6 mld | $2,08 mld | 10,1% | — | — | — | $0,14 | 2+ | — |
 Boston Scientific | BSX | Health Care Equipment | 2025 | $20,1 mld | $2,9 mld | 14,4% | 15,2% | 10,4% | — | — | — | +11,4% |
 Universal Health Services | UHS | Health Care Facilities | 2025 | $17,4 mld | $1,49 mld | 8,6% | 8,5% | 6,7% | 13,1% | $0,80 | 0 | −36,0% |
 IQVIA | IQV | Life Sciences Tools & Services | 2025 | $16,3 mld | $1,36 mld | 8,3% | 7,5% | 11,0% | 9,8% | — | — | +38,1% |
| Regeneron Pharmaceuticals | REGN | Biotechnology | 2025 | $14,3 mld | $4,5 mld | 31,4% | 11,0% | 13,3% | 22,3% | $3,52 | 0 | −5,8% |
 Viatris | VTRS | Pharmaceuticals | 2025 | $14,3 mld | −$3,51 mld | −24,6% | 3,7% | 4,3% | — | $0,48 | 0 | +134,6% |
| Labcorp | LH | Health Care Services | 2025 | $14 mld | $876 mln | 6,3% | −0,0% | 4,9% | 9,2% | $2,88 | 0 | −16,7% |
 DaVita | DVA | Health Care Services | 2025 | $13,6 mld | $747 mln | 5,5% | 3,4% | — | 22,9% | — | — | −64,9% |
| Henry Schein | HSIC | Health Care Distributors | 2025 | $13,2 mld | $398 mln | 3,0% | 5,4% | — | 1,4% | — | — | −27,7% |
 Vertex Pharmaceuticals | VRTX | Biotechnology | 2025 | $12 mld | $3,95 mld | 32,9% | 14,1% | 27,8% | — | — | — | +6,9% |
 Baxter International | BAX | Health Care Equipment | 2025 | $11,2 mld | −$957 mln | −8,5% | −0,7% | 1,2% | — | $0,52 | 0 | −6,6% |
| Quest Diagnostics | DGX | Health Care Services | 2025 | $11 mld | $992 mln | 9,0% | 3,2% | 3,9% | 6,0% | $3,20 | 15 | −22,1% |
 Intuitive Surgical | ISRG | Health Care Equipment | 2025 | $10,1 mld | $2,86 mld | 28,4% | 18,2% | 15,5% | 16,4% | — | — | +6,3% |
| Biogen | BIIB | Biotechnology | 2025 | $9,89 mld | $1,29 mld | 13,1% | −6,0% | −0,8% | −5,4% | — | — | −36,4% |
 Zoetis | ZTS | Pharmaceuticals | 2025 | $9,47 mld | $2,67 mld | 28,2% | 7,2% | 7,1% | 24,4% | $2,03 | 12 | −11,6% |
 Solventum | SOLV | Health Care Technology | 2025 | $8,32 mld | $1,56 mld | 18,7% | — | — | — | — | — | — |
 Zimmer Biomet | ZBH | Health Care Equipment | 2025 | $8,23 mld | $705 mln | 8,6% | 6,1% | 3,2% | 16,5% | $0,96 | 0 | +4,7% |
 Agilent Technologies | A | Life Sciences Tools & Services | 2025 | $6,95 mld | $1,3 mld | 18,8% | 5,4% | 5,6% | 14,3% | $0,99 | 10 | −14,9% |
 Edwards Lifesciences | EW | Health Care Equipment | 2025 | $6,07 mld | $1,07 mld | 17,7% | 6,7% | 9,3% | 9,3% | — | — | −11,4% |
 Steris | STE | Health Care Equipment | 2026 | $5,94 mld | $782 mln | 13,2% | 13,8% | 10,2% | 17,7% | $2,46 | 15 | +38,7% |
 ResMed | RMD | Health Care Equipment | 2026 | $5,65 mld | $1,52 mld | 26,9% | 12,1% | 11,9% | 15,4% | $2,40 | 5 | +3,1% |
 Incyte | INCY | Biotechnology | 2025 | $5,14 mld | $1,29 mld | 25,0% | 14,0% | 21,2% | 71,0% | — | — | +7,2% |
| Dexcom | DXCM | Health Care Equipment | 2025 | $4,66 mld | $836 mln | 17,9% | 19,3% | 27,8% | — | — | — | +27,0% |
 Illumina, Inc. | ILMN | Life Sciences Tools & Services | 2025 | $4,34 mld | $850 mln | 19,6% | 6,0% | 6,9% | 5,8% | — | — | +4,7% |
 Idexx Laboratories | IDXX | Health Care Equipment | 2025 | $4,3 mld | $1,06 mld | 24,6% | 9,7% | 10,4% | 20,4% | — | — | −13,5% |
 Cooper Companies (The) | COO | Health Care Supplies | 2025 | $4,09 mld | $375 mln | 9,2% | 11,0% | 8,6% | 6,1% | — | — | +1,6% |
 Align Technology | ALGN | Health Care Supplies | 2025 | $4,03 mld | $410 mln | 10,2% | 10,3% | 16,9% | 12,3% | — | — | −11,0% |
 Mettler Toledo | MTD | Life Sciences Tools & Services | 2025 | $4,03 mld | $869 mln | 21,6% | 5,5% | 5,3% | 12,9% | — | — | −26,9% |
 Charles River Laboratories | CRL | Life Sciences Tools & Services | 2025 | $4,02 mld | −$144 mln | −3,6% | 6,5% | 11,4% | — | — | — | +4,1% |
 Veeva Systems | VEEV | Health Care Technology | 2026 | $3,2 mld | $909 mln | 28,4% | 16,9% | 22,8% | 30,5% | — | — | +15,2% |
| Waters Corporation | WAT | Life Sciences Tools & Services | 2025 | $3,17 mld | $643 mln | 20,3% | 6,0% | 4,5% | 6,7% | — | — | −28,1% |
| West Pharmaceutical Services | WST | Health Care Supplies | 2025 | $3,07 mld | $494 mln | 16,1% | 7,4% | 8,2% | 18,0% | $0,86 | 17+ | −1,5% |
 Revvity | RVTY | Health Care Equipment | 2025 | $2,86 mld | $241 mln | 8,4% | 1,4% | 3,1% | 1,0% | $0,28 | 0 | +2,9% |
| Insulet Corporation | PODD | Health Care Equipment | 2025 | $2,71 mld | $247 mln | 9,1% | 24,5% | 26,2% | — | — | — | +26,6% |
 Moderna | MRNA | Biotechnology | 2025 | $1,94 mld | −$2,82 mld | −145,2% | 19,3% | — | — | — | — | — |
| Bio-Techne | TECH | Life Sciences Tools & Services | 2026 | $1,22 mld | $182 mln | 15,0% | 5,5% | 9,3% | 5,2% | $0,32 | 0 | +5,2% |
Ricavi e utile netto: l'ultimo esercizio completo. Crescita: tasso medio annuo su 5 o 10 anni. Dividendo: per azione nell'ultimo anno. Aumenti consecutivi: anni di fila con un dividendo per azione più alto; i dati della SEC partono dal 2009 (con il 2007–2008 come anni di confronto), quindi il segno + indica una serie che risale fino all'inizio dei dati dell'azienda. Azioni, 10 anni: variazione del numero di azioni; sotto zero significa riacquisti. —: non presente nei dati o non significativo.
Altri settori
Fonte: SEC EDGAR (documenti depositati dalle aziende), dati al 13 novembre 2026. Settori, sotto-industrie, sedi e date di ingresso nell'indice: Wikipedia, CC BY-SA 4.0.